Mode
Text Size
Log in / Sign up

Dalteparin

0 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials of Dalteparin

13 trials tracked of Dalteparin: 7 in phase 3 or 4 and 3 with published results. The most-cited published study has 1599 citations.

13Trials tracked
7Phase 3 & 4
0Recruiting
3With published results
Phase distribution
Phase 4 2 Phase 3 5 Phase 2 2 Other / NA 4
  1. Phase 3 Cancer Venous Thromboembolism (VTE) Completed · 1,599 cited
  2. Phase 3 Apixaban for the Treatment of Venous Thromboembolism in Patients With Cancer Completed · 1,028 cited
  3. Phase 3 Apixaban or Dalteparin in Reducing Blood Clots in Patients With Cancer Related Venous Thromboembolism Completed · 576 cited
  4. Phase 4 Evaluation of Dalteparin for Long-term (One Year) Treatment of Blood Clots in Subjects With Cancer Completed
  5. Phase 4 Dalteparin for Primary Venous Thromboembolism (VTE) Prophylaxis in Pancreatic Cancer Patients Completed
  6. Phase 3 Effectiveness of Bridging Anticoagulation for Surgery (The BRIDGE Study) Completed
Show 7 more trials
  1. Phase 3 PROSPER: PostpaRtum PrOphylaxiS for PE Randomized Control Trial Pilot Completed
  2. Phase 2 Fragmin for the Treatment of Acute VTE in Pediatric Cancer Patients Completed
  3. Phase 2 Treatment of Sickle Cell Patients Hospitalized in Pain Crisis With Prophylactic Dose Low-molecular-weight Heparin (LMWH) Versus Placebo Completed
  4. N/A Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in Cancer Completed
  5. N/A The Clinical Utility of Thrombelastography in Guiding Prophylaxis of Venous Thromboembolism Following Trauma Completed
  6. N/A Dalteparin in Preventing DVT in Participants With Cancer Completed
  7. N/A Effectiveness And Safety Of Dalteparin In Patients With Acute Coronary Syndromes Without ST Elevations In Clinical Practice Completed

Showing the 13 most-cited and recently-updated of 13 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
No published articles yet for this medication. Check back soon.